NVD-001

N/A

Report date: 2022/11/20 13:46:54

Base Information

Drug NameNVD-001
Drug Alias NameCreostNVD-001
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Somatic cell > Osteogenic cell therapy
Mechanisms of ActionOsteogenesis stimulantsStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsSpondylolisthesis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumPoland
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversite Catholique De Louvain
China Registration ClassN/A

Develop Information

Active CompaniesNovadip Biosciences SA
Inactive CompaniesN/A
Active IndicationsSpondylolisthesis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A